Inventor · disambiguated record
David M. Weiner
Also filed as: WEINER DAVID · WEINER DAVID M
19 granted patents·15 pending applications·628 citations·filing 1999–2021
97Inventor score
Files withACADIA PHARM INC21WEINER DAVID M6ACADIA PHARMACUETICALS INC1BURSTEIN ETHAN S1VAN KAMMEN DANIEL1
Top patents by PatentIndex Score
34 records- 0198US8921393B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2013·Granted Dec 30, 2014·41 cites·36 claims
- 0297US10028944B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2017·Granted Jul 24, 2018·15 cites·15 claims
- 0397US9566271B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2015·Granted Feb 14, 2017·17 cites·15 claims
- 0497US8377959B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2012·Granted Feb 19, 2013·26 cites·12 claims
- 0597US8008323B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2010·Granted Aug 30, 2011·25 cites·9 claims
- 0697US7994193B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2010·Granted Aug 9, 2011·29 cites·9 claims
- 0797US7732462B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted Jun 8, 2010·36 cites·24 claims
- 0897US7659285B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted Feb 9, 2010·33 cites·11 claims
- 0997US7601740B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2004·Granted Oct 13, 2009·60 cites·26 claims
- 1096US10525046B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2018·Granted Jan 7, 2020·12 cites·20 claims
- 1196US9211289B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2014·Granted Dec 15, 2015·20 cites·13 claims
- 1296US7713995B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted May 11, 2010·30 cites·15 claims
- 1395US8618130B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2013·Granted Dec 31, 2013·25 cites·15 claims
- 1495US7863296B2Selective serotonin receptor inverse agonists as therapeutics for diseaseACADIA PHARM INC·Filed 2005·Granted Jan 4, 2011·47 cites·18 claims
- 1594US8227487B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesWEINER DAVID M·Filed 2011·Granted Jul 24, 2012·25 cites·12 claims
- 1694US7875632B2Selective serotonin receptor inverse agonists as therapeutics for diseaseACADIA PHARM INC·Filed 2009·Granted Jan 25, 2011·23 cites·11 claims
- 1791US6358698B1Methods of identifying inverse agonists of the serotonin 2A receptorACADIA PHARMACUETICALS INC·Filed 1999·Granted Mar 19, 2002·131 cites·11 claims
- 1887US7820695B2Selective serotonin receptor inverse agonists as therapeutics for diseaseACADIA PHARM INC·Filed 2004·Granted Oct 26, 2010·25 cites·13 claims
- 1981US2022241265A1Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 2079US2024091212A1Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2021·Application pending·0 cites
- 2178US2020323836A1Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2019·Application pending·0 cites
- 2276US7348140B1Clinical indications for genotyping polymorphic variants of G-protein coupled receptorsACADIA PHARM INC·Filed 2002·Granted Mar 25, 2008·8 cites·4 claims
- 2363US2006199807A1Use of N-desmethylclozapine to treat human neuropsychia tric diseaseWEINER DAVID M·Filed 2006·Application pending·0 cites
- 2463US2006194831A1Use of N-desmethylclozapine to treat human neuropsychiatric diseaseWEINER DAVID M·Filed 2006·Application pending·0 cites
- 2562US2005148018A1Methods of identifying inverse agonists of the serotonin 2A receptorFiled 2005·Application pending·0 cites
- 2660US2005250767A1Use of N-desmethylclozapine to treat human neuropsychiatric diseaseWEINER DAVID M·Filed 2005·Application pending·0 cites
- 2759US2009018119A1Use of n-desmethylclozapine to treat human neuropsychiatric diseaseACADIA PHARM INC·Filed 2008·Application pending·0 cites
- 2856US2008051429A1Use of 4-amino-piperidines for treating sleep disordersVAN KAMMEN DANIEL·Filed 2007·Application pending·0 cites
- 2956US2005085463A1Use of N-desmethylclozapine to treat human neuropsychiatric diseaseFiled 2004·Application pending·0 cites
- 3055US2007275957A1Use of n-desmethylclozapine to treat human neuropsychiatric diseaseWEINER DAVID M·Filed 2007·Application pending·0 cites
- 3154US2005123964A1G-protein coupled receptors high-throughput functional assayFiled 2004·Application pending·0 cites
- 3253US2005261278A1Selective serotonin receptor inverse agonists as therapeutics for diseaseWEINER DAVID M·Filed 2004·Application pending·0 cites
- 3352US2004224942A1Use of N-desmethylclozapine to treat human neuropsychiatric diseaseFiled 2004·Application pending·0 cites
- 3450US2008280303A1G-protein coupled receptors high-throughput functional assayBURSTEIN ETHAN S·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David M. Weiner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →